je.st
news
Tag: shire
Shire PLC (SHP) Lifted to Outperform at BNP Paribas
2016-01-18 16:41:30| Biotech - Topix.net
The brokerage currently has a GBX 5,700 target price on the biopharmaceutical company's stock. BNP Paribas' price objective points to a potential upside of 36.20% from the company's previous close.
Drugmaker Shire wins Baxalta for $32 billion after six-month pursuit
2016-01-11 21:49:31| IT Services - Topix.net
Drugmaker Shire Plc clinched its six-month pursuit of Baxalta International Inc on Monday with an agreed $32 billion cash and stock offer, catapulting it to a leading position in treating rare diseases. The London-listed group, which first approached the U.S. firm with an all-stock offer in July, won over the maker of treatments for rare blood conditions, cancers and immune system disorders after adding a cash sweetener.
Tags: billion
wins
pursuit
shire
Shire buys US drugs rival for $32bn
2016-01-11 17:25:17| BBC News | Business | UK Edition
UK pharmaceutical firm Shire reaches a $32bn (22bn) deal for US rival Baxalta to create rare-disease drugs giant.
Shire to Combine with Baxalta in Deal Valued at About $32 Billion
2016-01-11 14:23:03| Biotech - Topix.net
Shire Plc agreed to buy Baxalta Inc. for about $32 billion to become the world's biggest maker of so-called orphan drugs for rare diseases. The price includes 0.1482 of Shire's American depositary receipts and $18 in cash for each Baxalta share held, the Dublin-based drugmaker said in a statement.
Tags: deal
billion
combine
valued
Zacks Investment Research Upgrades Shire PLC (SHPG) to "Hold"
2016-01-04 23:29:59| Biotech - Topix.net
According to Zacks, "Shire's third-quarter results were impressive with the company beating on both top- and bottom-line estimates. It holds a strong position in the ADHD market driven by Vyvanse.
Tags: research
hold
investment
upgrades
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] next »